Yanfen Fang
No. 19A Yuquan Road
Yuquan, 100049, China
Yuquan, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Rapid Identification of a Potent, Selective, and Orally Active p300/CBP Bromodomain Inhibitor Bearing an Imidazo[1,2-a]pyridine Scaffold via a Highly Efficient Four-Step Synthesis.
Journal: Journal of medicinal chemistry
Published: July 17, 2026
Discovery of CZL-149: A Novel, Highly Potent, and Orally Bioavailable Dual Inhibitor Targeting BET and p300/CBP Bromodomains with Strong Antitumor Efficacy.
Journal: Journal of medicinal chemistry
Published: May 18, 2026
Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy.
Journal: Bioorganic & medicinal chemistry letters
Published: April 14, 2026
Non-canonical function of transferrin receptor-1 promotes breast cancer metastasis by activating HCK‒STAT3‒MMP9 signalling.
Journal: Clinical and translational medicine
Published: March 16, 2026
Marine-Derived Bromotyrosine Alkaloids as Potent hCYP1B1 Inhibitors to Overcome Paclitaxel Resistance.
Journal: Journal of medicinal chemistry
Published: January 30, 2026
Switching Photocatalytic CO2 Reduction Path via Controlled Surface Hydroxylation in GO/CoTPP Hybrids.
Journal: Inorganic chemistry
Published: September 09, 2025
Discovery of Novel Tridentate Alkenyl Diacid Derivatives as Potent ATP Citrate Lyase Inhibitors for the Treatment of Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: July 16, 2025
Development of ASGR-Mediated Hepatocyte-Targeting Cytotoxic Drug Conjugates with CTSB-Cleavable Linkers Incorporating Succinimide and Succinic Acid Monoamide.
Journal: Journal of medicinal chemistry
Published: February 07, 2025
Long-circulating enzyme-activated HSP90-targeted camptothecin derivatives.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 19, 2024
Facet-induced fractionation of humic acid by hematite and the promoted-photodegradation of 17β-estradiol catalyzed by hematite-humic complex.
Journal: Journal of hazardous materials
Published: September 09, 2024
BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair.
Journal: Translational oncology
Published: July 12, 2024
Last Updated: 09/26/2026